The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: A Preclinical Review

다국어 초록 (Multilingual Abstract)

Nicotine, the primary psychoactive component of tobacco products, produces diverse neurophysiological, motivational, and behavioral effects through several brain regions and neurochemical pathways. Various neurotransmitter systems have been explored to understand the mechanisms behind nicotine tolerance, dependence, and withdrawal. Recent evidence suggests that glutamate neurotransmission has an important role in this phenomenon. The aim of the present review is to discuss preclinical findings concerning the role of N-methyl-D-aspartate (NMDA) receptor neurotransmission in mediating the behavioral effects of nicotine, tolerance, sensitization, dependence, and withdrawal. Based on preclinical findings, it is hypothesized that NMDA receptors mediate the common adaptive processes that are involved in the development, maintenance, and expression of nicotine addiction. Modulation of glutamatergic neurotransmission with NMDA receptor antagonists may prove to be useful in alleviating the symptoms of nicotine abstinence and facilitate tobacco-smoking cessation.

참고문헌 (Reference)

1 Imperato A, "preferentially stimulates dopamine release in the limbic system of freely moving rats" 132 : 337-338, 1986

2 Marks MJ, "of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin quinuclidinyl benzilate" 22 : 554-564, 1982

3 Cartmell J, "of neurotransmitter release by metabotropic glutamate receptors" 75 : 889-907, 2000

4 Laviolette SR, "he neurobiology of nicotine addiction: bridging the gap from molecules to behaviour" 5 : 55-65, 2004

5 Martin BR, "What is the nature of mecamylamine’s antagonism of the central effects of nicotine?" 38 : 3391-3397, 1989

6 Chergui K, "Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo" 5 : 137-144, 1993

7 Stewart J, "Tolerance and sensitization to the behavioral effects of drugs" 4 : 289-312, 1993

8 Wolf ME, "The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants" 54 : 679-720, 1998

9 Wolf ME, "The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants" 54 : 679-720, 1998

10 Wonnacott S, "The paradox of nicotinic acetylcholine receptor upregulation by nicotine" 11 : 216-219, 1990

11 Morrison CF, "The occurence of tolerance to a central depressant effect of nicotine" 46 : 151-156, 1972

12 Malin DH, "The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat" 115 : 180-184, 1994

13 Balfour DJ, "The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus accumbens" 6 : 899-912, 2004

14 Trujillo KA, "The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity" 4 : 373-391, 2002

15 Robinson TE, "The neural basis of drug craving: an incentive-sensitization theory of addiction" 18 : 247-291, 1993

16 Corrigall WA, "The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine" 107 : 285-289, 1992

17 Paterson NE, "The mGluR5 antagonist MPEP decreased nicotine self- administration in rats and mice" 167 : 257-264, 2003

18 Danysz W, "The involvement of NMDA receptors in acute and chronic effects of ethanol" 16 : 499-504, 1992

19 Birrell CE, "The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine" 140 : 142-149, 1998

20 U.S.Department of Health and Human Service.The health consequence of smoking.Nicotine addiction:A report of the Surgeon General.DHHS publication(CDC)88-, "The health consequence of smoking. Nicotine addiction: A report of the Surgeon General" Govt. printing office 88-8406, 1988

21 Dingledine R, "The glutamate receptor ion channels" 51 : 7-61, 1999

22 Collins ED, "The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans" 9 : 413-425, 1998

23 Herman BH, "The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction" 13 : 269-293, 1995

24 Rasmussen K, "The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle" 7 : 1050-1052, 1996

25 Nisell M, "Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area" 16 : 36-44, 1994

26 Hughes JR, "Symptoms of tobacco withdrawal. A replication and extension" 48 : 52-59, 1991

27 Yamakura T, "Subunit- and site-specific pharmacology of the NMDA receptor channel" 59 : 279-298, 1999

28 Rapier C, "Stereo selective nicotine induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation" 50 : 1123-1130, 1988

29 Corrigall WA, "Selective dopamine antagonists reduce nicotine self-administration" 104 : 171-176, 1991

30 Popik P, "Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice" 130 : 1425-1431, 2000

31 Shim I, "Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat" 443 : 119-124, 2002

32 Di Chiara G, "Role of dopamine in the behavioral actions of nicotine related to addiction" 393 : 295-314, 2000

33 Malin DH, "Rodent model of nicotine abstinence syndrome" 43 : 779-784, 1992

34 Moghaddam B, "Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats" 281 : 1349-1352, 1998

35 Suaud-Chagny MF, "Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental areas" 49 : 63-72, 1992

36 Chiamulera C, "Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice" 4 : 873-874, 2001

37 Schachter S, "Regulation, withdrawal nicotine addiction" 23 : 123-133, 1979

38 Fung YK, "Receptor mechanisms of nicotine- induced locomotor hyperactivity in chronic nicotine- treated rats" 152 : 263-271, 1988

39 Manzoni OJ, "Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal" 19 : 6629-6636, 1999

40 Inturrisi CE, "Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence" 9 : 110-119, 1997

41 Schenk S, "Pre-exposure to amphetamine but not to nicotine sensitizes rats to the motor activating effect of cocaine" 103 : 62-66, 1991

42 Sorenson EM, "Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat" 87 : 659-673, 1998

43 Rock DM, "Polyamine regulation of N-methyl-D-aspartate receptor channels" 35 : 463-482, 1995

44 Dopamine functions in appetitive and defensive behaviours, "Phillips AG. Dopamine functions in appetitive and defensive behaviours" 39 : 247-279, 1992

45 Martin TJ, "Pharmacological evaluation of the antagonism of nicotine’s central effects by mecamylamine and pempidine" 254 : 45-51, 1990

46 Corrigall WA, "Opiate antagonists reduce cocaine but not nicotine self-administration" 104 : 167-170, 1991

47 Dawson VL, "Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures" 88 : 6368-6371, 1991

48 Gioanni Y, "Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission" 11 : 18-30, 1999

49 Marks MJ, "Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes" 264 : 542-552, 1993

50 Kosowski AR, "Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551" 175 : 114-123, 2004

51 Shim I, "Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat" 121 : 137-147, 2001

52 Tripathi HL, "Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels" 221 : 91-96, 1982

53 Gomita Y, "Nicotine- induced tail-tremor and drug effects" 34 : 817-821, 1989

54 Helton DR, "Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor, reactivity" 113 : 205-210, 1993

55 Helton DR, "Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity" 113 : 205-210, 1993

56 Stolerman IP, "Nicotine tolerance in rats: role of dose and dose interval" 34 : 317-324, 1974

57 Reid MS, "Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization" 35 : 129-136, 2000

58 Corrigall WA, "Nicotine maintains robust self-administration in rats on a limited-access schedule" 99 : 473-478, 1989

59 Mansner R, "Nicotine induced tremor and antidiuresis and brain nicotine levels in the rat" 53 : 169-176, 1975

60 Malin DH, "Nicotine dependence: studies with a laboratory model" 43 : 779-784, 1992

61 Carroll ME, "Nicotine dependence in rats" 45 : 1381-1388, 1989

62 Clarke PB, "Nicotine and smoking: a perspective from animal studies" 92 : 135-143, 1987

63 Vezina P, "Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections" 261 : 484-490, 1992

64 Pidoplichko VI, "Nicotine activates and desensitizes midbrain dopamine neurons" 390 : 401-404, 1997

65 Kenny PJ, "Neurobiology of the nicotine withdrawal syndrome" 70 : 531-549, 2001

66 White FJ, "Neuroadaptations involved in amphetamine and cocaine addiction" 51 : 141-153, 1998

67 Malin DH, "Naloxone precipitates nicotine abstinence syndrome in the rat" 112 : 339-342, 1993

68 Monaghan DT, "NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology" 280 : 614-620, 1997

69 Liljequist S, "NMDA receptor antagonists inhibit ethanol produced locomotor stimulation in NMRI mice" 8 : 309-312, 1991

70 Popik P, "NMDA antagonist properties of the putative antiaddictive drug, ibogaine" 275 : 753-760, 1995

71 McBain CJ, "N-methyl-D-aspartic acid receptor structure and function" 74 : 723-760, 1994

72 Schilstrom B, "N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens" 82 : 781-789, 1998

73 Elliott K, "N-methyl- D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development" 13 : 347-356, 1995

74 Nakanishi S, "Molecular diversity of glutamate receptors and implications from brain functions" 258 : 597-603, 1992

75 Wroblewski JT, "Modulation of glutamate receptors: molecular mechanisms and functional implications" 29 : 441-474, 1989

76 Johnson TD, "Modulation of channel function by polyamines" 17 : 22-27, 1996

77 Hesselink MB, "Modifications of the behavioral profile of non- competitive NMDA receptor antagonists, memantine, amantadine and (+) MK-801 after chronic administration" 10 : 85-98, 1999

78 Schoepp DD, "Metabotropic glutamate receptors in brain function and pathology" 14 : 13-20, 1993

79 Clarke PB, "Mesolimbic dopamine activation--the key to nicotine reinforcement?" 152 : 162-168, 1990

80 Rose JE, "Mecamylamine increase nicotine preference and attenuates nicotine discrimination" 32 : 933-938, 1989

81 Shoaib M, "MK-801 attenuates behavioral adaptation to chronic nicotine administration in rats" 105 : 514-515, 1992

82 Wise RA, "MK-801 (dizocilipine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization" 22 : 362-368, 1996

83 Carlezon WA Jr, "MK 801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation" 20 : 1-9, 1995

84 Kelsey JE, "Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats" 161 : 370-378, 2002

85 Mansvelder HD, "Long-term potentiation of excitatory inputs to brain reward areas by nicotine" 27 : 349-357, 2000

86 Reavill C, "Locomotor activity in rats after administration of nicotinic agonists intracerebrally" 99 : 273-279, 1990

87 Fu Y, "Local alpha- bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo" 101 : 369-375, 2000

88 Morley BJ, "Light-dark variation in response to chronic nicotine treatment and the density of hypothalamic alpha-bungarotoxin receptors" 37 : 239-245, 1990

89 Damsma G, "Lack of tolerance to nicotine- induced dopamine release in the nucleus accumbems" 168 : 363-368, 1989

90 Helton DR, "LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats" 36 : 1511-1516, 1997

91 Damaj MI, "Is the dopaminergic system involved in the central effects of nicotine in mice?" 111 : 106-108, 1993

92 Kalivas PW, "Involvement of N-methyl- D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine" 267 : 486-495, 1993

93 Meltzer LT, "Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine" 15 : 21-16, 1981

94 Reavill C, "Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behavior in rats" 1 : 264-273, 1987

95 Fidecka S, "Interaction between ketamine and ethanol in rats and mice" 41 : 23-32, 1989

96 Di Iorio P, "Interaction between A1 adenosine and class II metabotropic glutamate receptors in the regulation of purine and glutamate release from rat hippocampal slices" 67 : 302-309, 1996

97 Nisell M, "Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release" 75 : 348-352, 1994

98 Davidson M, "Increased NMDA- induced excitability during ethanol withdrawal: a behavioural and histological study" 674 : 91-96, 1995

99 Robinson TE, "Incentive-sensitization and addiction" 96 : 103-114, 2001

100 Bisaga A, "In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D- aspartate (NMDA) antagonists" 59 : 1-15, 2000

101 Maisonneuve IM, "Ibogaine and the dopaminergic response to nicotine" 129 : 249-256, 1997

102 Gray R, "Hippocampal synaptic transmission enhanced by low concentrations of nicotine" 383 : 713-716, 1996

103 Danysz W, "Glycine and N-methyl-D- aspartate receptors: physiological significance and possible therapeutic applications" 50 : 597-664, 1998

104 .Fiorino DF, "Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization" 142 : 200-208, 1999

105 Smith BR, "Exposure to nicotine enhances acquisition of ethanol drinking by laboratory rats in a limited access paradigm" 142 : 408-412, 1999

106 Costall B, "Exploration of mice in a black and white test box: validation as a model of anxiety" 32 : 777-785, 1989

107 Herrling PL, "Excitatory amino acids: Clinical results with antagonists" Academic Press 1997

108 Trujillo KA, "Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence" 37 : 139-154, 1995

109 Iyaniwura TT, "Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain" 158 : 73-79, 2001

110 O’Neill MF, "Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats" 104 : 343-350, 1999

111 Jain R, "Evidence for a role of nitric oxide in nicotine precipitated withdrawal in the rat" 6 : 873-, 2004

112 Corrigall WA, "Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment" 33 : 559-562, 1989

113 Taylor JR, "Enhanced responding for conditioned reward produced by intra-accumbens amphetamine is potentiated after cocaine sensitization" 142 : 31-40, 1999

114 Tzschentke TM, "Effects of the non- competitive NMDA-receptor antagonist memantine on morphine- and cocaine-induced potentiation of lateral hypothalamic brain stimulation reward" 149 : 225-234, 2000

115 Karcz-Kubicha M, "Effects of post-ethanol administration of NMDA and non-NMDA receptor antagonists on the development of ethanol tolerance in C57B1 mice" 120 : 49-56, 1995

116 Stitzer M, "Effects of nicotine on fixed-interval behavior and their modification by cholinergic antagonists" 171 : 166-177, 1970

117 Hendry JS, "Effects of nicotine on conditioned and unconditioned behaviors in experimental animals" 1 : 431-454, 1982

118 Singer G, "Effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule induced self injection of nicotine in the rat" 17 : 579-581, 1982

119 Cronan T, "Effects of chronically administered nicotine and saline on motor activity in rats" 22 : 897-899, 1985

120 Jain R, "Effect of selective dopaminergic drugs in Nicotine tolerant rats" 63 : S72-, 2001

121 Toth E, "Effect of nicotine on the level of extracellular amino acids in the hippocampus of rat" 21 : 903-907, 1996

122 Koob GF, "Drug addiction, dysregulation of reward, and allostasis" 24 : 97-129, 2001

123 Di Chiara G, "Drug addiction as dopamine-dependent associative learning disorder" 375 : 13-30, 1999

124 Epping-Jordan MP, "Dramatic decreases in brain reward function during nicotine withdrawal" 393 : 76-79, 1998

125 Carboni E, "Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats" 58 : 93-102, 2000

126 Carboni EG, "Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats" 58 : 93-124, 2000

127 Steppuhn KG, "Diazepam dependence prevented by glutamate antagonists" 90 : 6889-6893, 1993

128 Monyer H, "Developmental and regional expression in the rat brain and functional properties of four NMDA receptors" 12 : 529-540, 1994

129 Gonzalez P, "Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists" 332 : 257-262, 1997

130 Harris GC, "Critical role for ventral tegmental glutamate in preference for a cocaine- conditioned environment" 28 : 73-76, 2003

131 Nisell M, "Condition- independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat" 22 : 369-381, 1996

132 Hollmann M, "Cloned glutamate receptors" 17 : 31-108, 1994

133 Popik P, "Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test" 51 : 223-231, 1999

134 Bisaga A, "Clinical studies using NMDA receptor antagonists in cocaine and opioid dependence" Humana Press 261-270, 2002

135 Herman BH, "Clinical medications development for opiate addiction: focus on non opioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention" 9 : 158-172, 1997

136 Vallejo YF, "Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism" 25 : 5563-5572, 2005

137 Levin ED, "Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats" 39 : 441-444, 1987

138 Sershen H, "Characterization of multiple sites of action of ibogaine" 56 : 115-133, 2001

139 Hall GH, "Changes in body temperature produced by cholinomimetic substances injected into the cerebral ventricles of unanaesthetized cats" 4 : 634-641, 1972

140 Kalivas PW, "Cellular mechanisms of behavioral sensitization to drugs of abuse" 654 : 128-135, 1992

141 Koob GF, "Cellular and molecular mechanisms of drug dependence" 242 : 715-723, 1988

142 Shoaib M, "Brain sites mediating the discriminative stimulus effects of nicotine in rats" 78 : 183-188, 1996

143 Jain R, "Biological basis of nicotine addiction" 35 : 281-289, 2003

144 Shoaib M, "Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists" 111 : 1073-1080, 194

145 Shoaib M, "Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist" 134 : 121-130, 1997

146 Shoaib M, "Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist" 105 : 514-515, 1997

147 Hildebrand BE, "Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms" 129 : 348-356, 1997

148 Malin DH, "Auricular microelectrostimulation: naloxone reversible attenuation of opiate abstinence syndrome" 24 : 886-890, 1988

149 Collins AC, "Are nicotinic receptors activated or inhibited following chronic nicotine treatment?" 38 : 231-242, 1996

150 Trujillo KA, "Are NMDA receptors involved in opiate- induced neural and behavioral plasticity? A review of preclinical studies" 151 : 121-141, 2000

151 Wu KM, "An analysis of nicotinic and opioid processes in the medulla oblongata and nucleus ambiguus of the dog" 227 : 302-307, 1983

152 Wolf ME, "Amphetamine increases glutamate efflux in the rat ventral tegmental area by a mechanism involving glutamate transporters and reactive oxygen species" 75 : 1634-1644, 2000

153 Danysz W, "Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents-preclinical studies" 21 : 455-468, 1997

154 Kampman KM, "Amantadine in the treatment of cocaine- dependent patients with severe withdrawal symptoms" 157 : 2052-2054, 2000

155 Thompson DF, "Amantadine in the treatment of cocaine withdrawal" 26 : 933-934, 1992

156 Shoptaw S, "Amantadine hydrochloride is effective treatment for cocaine dependence (abstract)" 179 : 55-, 1998

157 Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020: Global Burdan of Disease Study" 349 : 1498-1504, 1997

158 Vanderschuren LJ, "Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies" 151 : 99-120, 2000

159 Stolerman IP, "Acute and chronic tolerance to nicotine measured by activity in rats" 30 : 329-342, 1973

160 Rasmussen K, "A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal" 15 : 497-505, 1996

161 Stephens DN, "A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands" 6 : 425-446, 1995

162 Balfour DJ, "A comparison of the effects of nicotine and (+) amphetamine on rat behaviour in an unsignalled Sidman avoidance schedule" 42 : 257-260, 1990